The LDN Shop
Visit our e-commerce website for Conferences, Webinars, Medical Membership, eBooks etc
LDN Social Media
Get connected with us on social networks
LDN Community
Join our community here.
Off-label, Low-Dose Naltrexone for Refractory Chronic Low Back Pain
Pain Med
May 2014
https://europepmc.org/article/med/24967470
Serious adverse events reported in placebo randomised controlled trials of oral naltrexone: a systematic review and meta-analysis
BMC Medicine
15 January 2019
https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-018-1242-0
Low-dose naltrexone inhibits the epithelial-mesenchymal transition of cervical cancer cells in vitro and effects indirectly on tumor-associated macrophages in vivo
Int Immunopharmacol
September 2020
https://pubmed.ncbi.nlm.nih.gov/32585612/
Dr. Armin Schwarzbach, Infections in Cancer and Autoimmune Disorders. Presented by Markus Berger.
Mark Mandel, PharmD - LDN and Pets (2017 Conference) (LDN, low dose naltrexone)
Albeit a brief ten minute presentation, Dr Mandel proves to demonstrate how Low Dose Naltrexone (LDN) can be effective in treating inflammatory conditions in not only humans but also dogs and other pets.
Dana Flavin, MD - Reversing Cancer with Biochemistry (2018 Conference) (LDN, low dose naltrexone)
Dr Dana Flavin shares her presentation on Reversing Cancer at the LDN 2018 Conference.
Akbar Khan, MD - Cancer Case Studies (2016 Conference) (LDN, low dose naltrexone)
In this presentation Dr Khan talks about many case studies involving Transitional cell carcinoma (TCC), colon cancer and Adenoid cystic carcinoma (ACC), explaining how Low Dose Naltrexone (LDN) can improve the lives of cancer patients.
Akbar Khan, MD - Cancer Therapy (2016 Conference) (LDN, low dose naltrexone)
Nasha Winters, ND - Navigating the Narrative (2017 Conference) (LDN, low dose naltrexone)
Dr Nasha Winters speaks from experience when she talks about Cancer and how to be proactive in preventing and/or combating it. In her youth she was diagnosed with a terminal Cancer, but discovered the life changes that would turn it around.
Akbar Khan, MD - Breaking the Cycle of Toxic Therapy (2017 Conference) (LDN, low dose naltrexone)
In this presentation Dr Khan talks about finding alternative treatments to treating cancer other than the conventional cytotoxic methods including chemotherapy, which can harm the body significantly.